Biliary-tract cancer: improving therapy by adding molecularly targeted agents

Lars Henrik Jensen

doi:10.1016/S1470-2045(11)70329-1

Biliary-tract cancer: improving therapy by adding molecularly targeted agents

Lars Henrik Jensen

IRS - Sygehus Lillebælt, Forskningsenhed for Onkologi (Vejle)

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Lancet Oncology
Vol/bind	13
Udgave nummer	2
Sider (fra-til)	118-119
ISSN	1470-2045
DOI	https://doi.org/10.1016/S1470-2045(11)70329-1
Status	Udgivet - 2012

Dokumenter og links

10.1016/S1470-2045(11)70329-1

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{c67c5796da714d7d98eed59623085faa,

title = "Biliary-tract cancer: improving therapy by adding molecularly targeted agents",

keywords = "Antineoplastic Combined Chemotherapy Protocols, Biliary Tract Neoplasms, Cholangiocarcinoma, Deoxycytidine, Erlotinib Hydrochloride, Female, Gallbladder Neoplasms, Humans, Male, Organoplatinum Compounds, Quinazolines",

author = "Jensen, \{Lars Henrik\}",

year = "2012",

doi = "10.1016/S1470-2045(11)70329-1",

language = "English",

volume = "13",

pages = "118--119",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Biliary-tract cancer

T2 - improving therapy by adding molecularly targeted agents

AU - Jensen, Lars Henrik

PY - 2012

Y1 - 2012

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Biliary Tract Neoplasms

KW - Cholangiocarcinoma

KW - Deoxycytidine

KW - Erlotinib Hydrochloride

KW - Female

KW - Gallbladder Neoplasms

KW - Humans

KW - Male

KW - Organoplatinum Compounds

KW - Quinazolines

U2 - 10.1016/S1470-2045(11)70329-1

DO - 10.1016/S1470-2045(11)70329-1

M3 - Journal article

C2 - 22192730

SN - 1470-2045

VL - 13

SP - 118

EP - 119

JO - Lancet Oncology

JF - Lancet Oncology

IS - 2

ER -